Missing/wrong data?
Log in to edit
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.
scientific article
Author/s
author: Daniil Stroyakovskiy, Xavier Pivot, Elżbieta Starosławska
Work details
Publication date
May 20, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.